Back

Does the relationship between time-varying achieved HbA1c and risk of coronary events depend on haptoglobin phenotype within the Action for Health in Diabetes (Look AHEAD) study?

25 April 2024 (09:00 - 12:30)
Organised by: Logo
Congress Presentation Part of: Understanding cardiovascular risk in Type 2 diabetes: mechanisms and markers Diabetes and the Heart Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Ms Allie Carew

Dalhousie University, Halifax (Canada)

7 More presentations in this session

Presentation thumbnail
Assessing microvascular function in adults with type II diabetes using near-infrared spectroscopy: Implications for exercise capacity
Mr M. Michielsen (Leuven, BE)
Abstract Slides
Presentation thumbnail
Association between oxidative balance score and diabetes among PURE Poland study participants
Assistant Professor D. Rozanska (Wroclaw, PL)
Abstract Slides
Presentation thumbnail
Prognostic value of new and established cardiovascular risk factors for incident diabetes mellitus in patients with chronic coronary syndrome
Professor D. Rothenbacher (Ulm, DE)
Abstract Slides
Presentation thumbnail
The relationship between cardiovascular risk factors and cardiovascular fitness and physical activity in patients with T2DM and prediabetes
Professor E. Calik (Ankara, TR)
Abstract Slides
Presentation thumbnail
The frequency of coronary artery atherosclerotic plaques in patients with newly diagnosed type 2 diabetes mellitus
Associate Professor A. Bakalli (Pristina, XK)
Abstract Slides

Access the full session

Session thumbnail
Understanding cardiovascular risk in Type 2 diabetes: mechanisms and markers

The Event

Event poster

ESC Preventive Cardiology 2024

25 April - 27 April 2024
You may be interested in
thumbnail
Congress Presentation
Case 1 - a middle-aged male with T2DM: polypharmacy in a primary prevention setting
thumbnail
Congress Presentation
Cardiovascular risk reduction: should we target pre-diabetes?
thumbnail
Congress Presentation
Diabetes as a major comorbidity in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources